These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20607268)

  • 21. Multidrug-resistant Acinetobacter baumannii infection in children.
    De Luca M; Angelino G; Calò Carducci FI; Martino A; Bernardi S; Bernaschi P; Carletti M; D'Argenio P; Palma P
    BMJ Case Rep; 2011 Aug; 2011():. PubMed ID: 22688471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acinetobacter baumannii infection in solid organ transplant recipients.
    Kitazono H; Rog D; Grim SA; Clark NM; Reid GE
    Clin Transplant; 2015 Mar; 29(3):227-32. PubMed ID: 25580999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
    Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of postoperative multidrug-resistant Acinetobacter baumannii meningitis by tigecycline.
    Kooli I; Brahim HB; Kilani M; Gannouni C; Aouam A; Toumi A; Loussaief C; Hattab MN; Chakroun M
    J Glob Antimicrob Resist; 2016 Jun; 5():62-3. PubMed ID: 27436468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
    Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M
    Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vivo and In Vitro Efficacy of Minocycline-Based Combination Therapy for Minocycline-Resistant Acinetobacter baumannii.
    Yang YS; Lee Y; Tseng KC; Huang WC; Chuang MF; Kuo SC; Lauderdale TL; Chen TL
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4047-54. PubMed ID: 27114274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals.
    Al-Sweih NA; Al-Hubail MA; Rotimi VO
    J Chemother; 2011 Feb; 23(1):13-6. PubMed ID: 21482488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bloodstream infections caused by Acinetobacter species with reduced susceptibility to tigecycline: clinical features and risk factors.
    Park GE; Kang CI; Cha MK; Cho SY; Seok H; Lee JH; Kim JY; Ha YE; Chung DR; Peck KR; Lee NY; Song JH
    Int J Infect Dis; 2017 Sep; 62():26-31. PubMed ID: 28676346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipients.
    Shields RK; Clancy CJ; Gillis LM; Kwak EJ; Silveira FP; Massih RC; Eschenauer GA; Potoski BA; Nguyen MH
    PLoS One; 2012; 7(12):e52349. PubMed ID: 23285002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
    Ye JJ; Lin HS; Yeh CF; Wu YM; Huang PY; Yang CC; Huang CT; Lee MH
    BMC Infect Dis; 2016 Aug; 16():374. PubMed ID: 27496018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia.
    Wood GC; Hanes SD; Boucher BA; Croce MA; Fabian TC
    Intensive Care Med; 2003 Nov; 29(11):2072-6. PubMed ID: 14556048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
    Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R
    J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors and molecular epidemiology of Acinetobacter baumannii bacteremia in neonates.
    Lee HY; Hsu SY; Hsu JF; Chen CL; Wang YH; Chiu CH
    J Microbiol Immunol Infect; 2018 Jun; 51(3):367-376. PubMed ID: 28830746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vitro tigecycline and carbapenem susceptibilities of clinical Acinetobacter baumannii isolates].
    Nayman Alpat S; Aybey AD; Akşit F; Ozgüneş I; Kiremitçi A; Usluer G
    Mikrobiyol Bul; 2010 Oct; 44(4):641-5. PubMed ID: 21063976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of clinical and microbiological efficacy of antibiotic regimens against Acinetobacter baumannii.
    Ackerman BH; Haith LR; Patton ML; Guilday RE; Reigart CL; Stair-Buchmann M
    J Burn Care Res; 2013; 34(4):403-12. PubMed ID: 23237825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia.
    Zeng J; Zhang L; Gao M; Wu J; Wu H; Chen J; Chen X; Tang W
    Int J Infect Dis; 2017 Aug; 61():23-26. PubMed ID: 28572073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.
    Khawcharoenporn T; Pruetpongpun N; Tiamsak P; Rutchanawech S; Mundy LM; Apisarnthanarak A
    Int J Antimicrob Agents; 2014 Apr; 43(4):378-82. PubMed ID: 24613422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical implication and prognostic predictors of tigecycline treatment for pneumonia involving multidrug-resistant Acinetobacter baumannii.
    Ye JJ; Lin HS; Kuo AJ; Leu HS; Chiang PC; Huang CT; Lee MH
    J Infect; 2011 Nov; 63(5):351-61. PubMed ID: 21846481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii.
    Schafer JJ; Goff DA; Stevenson KB; Mangino JE
    Pharmacotherapy; 2007 Jul; 27(7):980-7. PubMed ID: 17594203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.